JCGGDB TOP GlycoScience Protocol Online Database

Enzyme assay of GAG glycosyltransferases for chondroitin sulfate
Text Search

Enzyme assay of GAG glycosyltransferases for chondroitin sulfate

Authors:
Introduction Protocol References Credit lines
Category
Glycosyltransferases & related proteins
Protocol Name

Enzyme assay of GAG glycosyltransferases for chondroitin sulfate

Authors
Nadanaka, Satomi
Department of Biochemistry, Kobe Pharmaceutical University

Kitagawa, Hiroshi *
Department of Biochemistry, Kobe Pharmaceutical University
*To whom correspondence should be addressed.
KeyWords
Reagents

GlcAT-I activities

Substrate: Gal β1-3Gal β1-4Xyl*

Donor: UDP-[U - 14C]GlcA (285.2 mCi/mmol) (PerkinElmer, Waltham, MA)

* Gal β1-3Gal β1-4Xyl, an acceptor substrate for GlcAT-I, was a gift from Dr. Nancy B. Schwartz (University Chicago).

CS-GlcAT-II activities

Substrate: polymer chondroitin (Seikagaku Corporation, Tokyo, Japan, Cat No. 400640)

Donor: UDP-[U - 14C]GlcA (285.2 mCi/mmol) (PerkinElmer)

GalNAcT-II activities

Substrate: polymer chondroitin (Seikagaku Corporation, Cat No. 400640)

Donor: UDP-[3H]GalNAc (10 Ci/mmol) (PerkinElmer)

Polymerization activities

Substrate: GlcAβ1-3Galβ1-O-C2H4NH-benzyloxycarbonyl (chemically-synthesized linkage region analog) or

GlcAβ1-3Galβ1-3Galβ1-4Xylβ1-O-Ser** (chemically-synthesized tetrasaccharide serine)

Donor: UDP-[3H]GalNAc (10 Ci/mmol) and UDP-[U - 14C]GlcA (285.2 mCi/mmol) (PerkinElmer)

** Acceptor substrates for the polymerization reaction, GlcAβ1-3Galβ1-O-C2H4NH-benzyloxycarbonyl and GlcAβ1-3Galβ1-3Galβ1-4Xylβ1-O-Ser, were kindly provided from Prof. Jun-ichi Tamura (Tottori University).

Instruments

GlcAT-I activities

Chip column packed with Dowex 1-X8 (PO42- form)

2300TR liquid scintillation counter (PerkinElmer)

GalNAcT-II activities and CS-GlcAT-II activities

Syringe column (TERUMO SS-01T) packed with Superdex G-25 superfine (GE Healthcare, Little Chalfont, UK)1)

2300TR liquid scintillation counter (PerkinElmer)

Polymerization activities

Superdex Peptide HR 10/30 or Superdex 200 10/300 GL (GE Healthcare)

FPLC

2300TR liquid scintillation counter (PerkinElmer)

Methods
1.

Enzyme assay of GAG glycosyltransferases for chondroitin sulfate

1) 

 The following reaction mixtures of a total volume of 30 μL are prepared.

GlcAT-I activities

10 μL of enzyme source (see Comment *)

50 mM MES-NaOH (pH 6.5)

2 mM MnCl2

Gal β1-3Gal β1-4Xyl (1 nmol)

14.3 μM UDP-[14C]GlcA (approx. 1.46 × 105 dpm)

CS-GlcAT-II activities

10 μL of enzyme source

50 mM MES-NaOH (pH 6.5)

10 mM MnCl2

Chondroitin (171 μg)

14.3 μM UDP-[14C]GlcA (approx. 1.46 × 105 dpm)

GalNAcT-II activities

10 μL of enzyme source

50 mM MES-NaOH (pH 6.5)

10 mM MnCl2

171 μM ATP-Na

Chondroitin (171 μg)

8.57 μM UDP-[3H]GalNAc (approx. 3.60 × 105 dpm)

Polymerization activities

10 μL of enzyme source (Co-expression of at least two enzyme proteins is required for the polymerization reaction)

100 mM MES-NaOH (pH 6.5)

10 mM MnCl2

GlcAβ1-3Galβ1-O-C2H4NH-benzyloxycarbonyl (100 nmol) (see Comment **)

250 μM UDP-[3H]GalNAc (approx. 50.0 × 105 dpm)

250 μM UDP-GlcA

Comment 1
2) 

 Reaction mixtures of GlcAT-I, CS-GlcAT-II, and GalNAcT-II are incubated at 37˚C for 2 h.

Polymerization reaction is performed at 37˚C for 12 h.

Comment 0
3) 

 Each enzyme activity is measured according to the following method.

GlcAT-I activities (Fig. 2)

i) Preparation of chip columns 2)

Pipet chip (1 mL)

↓ pack with Dowex 1-X8 equilibrated with 5 mM phosphate buffer (pH 6.8).

Dowex 1-X8 (PO42- form)

ii) Assay

GlcAT-I reaction products

↓ add 1 mL of 5 mM phosphate buffer (pH 6.8).

↓ apply to a chip column.

↓ wash a chip column with 1 mL of 5 mM phosphate buffer (pH 6.8).

Flow-through and wash fractions (2 mL)

↓ analyze the radioactivity of the effluent fractions.

GalNAcT-II and CS-GlcAT-II activities (Fig. 3) 3)

i) Preparation of syringe columns

Syringe columns (TERUMO SS-01T)

↓ pack with Sephadex G-25 (superfine) equilibrated with 0.2 M NH4HCO3.

↓ centrifuge at 800 rpm for 5 min.

↓ centrifuge again at 2,000 rpm for 5 min.

ii) Assay

Samples (30 μL)

↓ add 20 μL of 0.2 M NH4HCO3.

Samples (50 μL)

↓ apply to the packed syringe column.

↓ centrifuge at 2,000 rpm for 5 min.

↓ add 50 μL of 0.2 M NH4HCO3 to the top of the syringe columns.

↓ centrifuge at 2,000 rpm for 5 min.

Eluates

↓ measure by scintillation counter.

Polymerization activities (Fig. 4) 4)

The reaction products

↓ analyze using a Superdex Peptide HR 10/30 column (see Comment *).

↓ measure radioactivity using a liquid scintillation counter.

Comment 1
4) 

 Each reaction product is confirmed.

GlcAT-I-reaction products

GlcAT-I reaction products

↓ pool and evaporate.

GlcAT-I reaction products

↓ digest with 22 mIU of β-glucuronidase (EC 4.2.2.5, Prozyme Inc. Code No. GKGAG-5007)

in a total volume of 30 μL of 50 mM sodium citrate buffer (pH 4.5) at 37˚C overnight.

↓ analyze digested or undigested samples on a Asahipak GS-320 column (GL Science Inc., Tokyo, Japan).

The radioactivity of the GlcAT-I-reaction products is released by digestion with β-glucuronidase and

eluted at the free [14C]GlcA position.

CS-GlcAT-II and GalNAcT-II-reaction products

CS-GlcAT-II or GalNAcT-II reaction products

↓ pool and evaporate.

CS-GlcAT-II or GalNAcT-II reaction products (100-200 μg)

↓ digest with 100 mIU of chondroitinase AC-II (Seikagaku Corporation) in a total volume of 30 μL of 50 mM

sodium acetate buffer (pH 6.0) at 37˚C overnight.

↓ analyze by a Superdex peptide HR 10/30 column.

The radioactivity peak of the CS-GlcAT-II and GalNAcT-II-reaction products eluted near the void volume

is subjected to digestion with chondroitinase AC-II and shifted to [14C]GlcAβ1-3GalNAc and free [3H]GalNAc

position, respectively.

Polymerized products

Polymerized products (Fig. 4)

↓ pool and evaporate.

Polymerized products

↓ digest with 100 mIU of chondroitinase AC-II (Seikagaku Corporation) in a total volume of 30 μL of 50 mM

sodium acetate buffer (pH 6.0) at 37˚C overnight.

↓ analyze using a Superdex peptide HR 10/30 column.

The radioactivity peak of the polymerized products eluted near the void volume is degraded by digestion

with chondroitinase AC-II and shifted to the elution position of the unsaturated disaccharide.

Comment 0
Figure & Legends

Figure & Legends

Fig. 1. The six cloned members involved in the CS biosynthesis.

(A) Schematic structures of six genes are shown. Highly conserved regions are indicated by gray bars. White bars show DXD motif. a.a., amino acid; TM, transmembrane domain. In addition, glycosyltransferase activities detected in each gene product are summarized. (B) The biosynthesis of CS in mammals. Mammalian CS is biosynthesized by multiple combinations of at least two proteins out of ChSy-1, ChSy-2, ChSy-3, and ChPF. It has been reported that ChGalNAcT-I and ChGalNAcT-II control the number of CS chains attached to a core protein and the length of CS chains, respectively.

 

 

 

 

Fig. 2. Measurement of GlcAT-I activities by chip column assay.

 

 

 

 

Fig. 3. GalNAcT-II and CS-GlcAT-II assays using a syringe column.

 

 

Fig. 4. Analysis of polymerized CS chains.

(A) The polymerization reaction products were analyzed on a Superdex peptide column.

(B) Molecular size of CS chains formed by the different combination of enzymes was determined by gel filtration chromatography on a Superdex 200 column. White arrowheads indicate the elution positions of commercial dextrans of known molecular weights.

Copyrights Creative Commons License   Attribution-Non-Commercial Share Alike
This work is released underCreative Commons licenses
Date of registration:2014-09-11 16:10:06
©2010 - 2023 Ritsumeikan University, AIST & JCGGDB. All Rights Reserved